SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Mark One)
[X] Quarterly report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 for the quarterly period ended March 31, 1997 or
[ ] Transition report pursuant to Section 13 or 15(d) of the Securities
Exchange Act for the transition period from ___________ to __________
Commission file number 0-19815
-------
CareMatrix Corporation
----------------------
(Exact name of registrant as specified in its charter)
Delaware 04-3069586
-------- ----------
(State or other jurisdiction of (IRS Employer Identification No.)
incorporation or organization)
197 First Avenue, Needham, Massachusetts 02194
----------------------------------------------
(Address of principal executive offices, including zip code)
(617) 433-1000
--------------
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes [X] No [ ]
There were 17,150,211 shares of the registrant's common stock, par value
$.05 per share, outstanding at August 6, 1997.
<PAGE>
PART II. OTHER INFORMATION
Item 2(c). Changes in Securities: On February 28, 1997, CareMatrix
Corporation (the "Company") issued to North Shore Health System
("North Shore") an immediately exercisable warrant to purchase
50,000 shares of the Company's common stock, par value $.05 per
share, in partial consideration for an agreement dated December
31, 1996, pursuant to which the Company and North Shore agreed to
acquire, develop, own, finance, manage and operate certain
assisted living projects. The initial exercise price of the
warrant is $13.125 per share (which was the per share price of
the Company's common stock on December 31, 1996), subject to
adjustment for stock splits, stock dividends and other similar
action with respect to the Company's common stock. The warrant
was issued pursuant to an exemption from registration under
Section 4(2) of the Securities Act of 1933, as amended.
* * *
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CAREMATRIX CORPORATION
August 12, 1997 By: /s/ Robert M. Kaufman
-------------------------------
Robert M. Kaufman
Chief Executive Officer and
Principal Accounting Officer
